New Healixia logo
Search
Search

Past events

Healixia saw the light of day early 2020. Below you find all the past events of Healixia, and - for the sake of completeness - also of the former associations (ACRP, BAPU, BeAPP and BRAS) that joined forces within Healixia. 

Past events

  1. Healixia workshop: How to read and implement the Investigator Brochure (IB)

    Designed as a practical afternoon session with lunch beforehand, this workshop will combine expert introductions on regulations, protocol integration and risk analysis with a hands-on group exercise using two real-life case examples.
    Read more

  2. Human Pharmacology course: Pharmacokinetics, pharmacodynamics and biomarkers in early clinical development

    Full
    Healixia/EUFEMED Certificate Course in Human Pharmacology - Module 4
    Read more

  3. Healixia symposium: Strengthening the landscape for Early Phase clinical studies in Belgium

    Join us for an insightful afternoon. Now open for registration!
    Read more

  4. Healixia seminar: From CTD to CTR - How to keep Belgium attractive for early phase development in EU

    From January 2023 onwards all clinical trial applications, including phase 1 trials, need to be submitted according to the new Clinical Trial Regulation (CTR). In this meeting, all stakeholders are brought together and given the opportunity to express their perceived challenges and opportunities as we move into this new legislative framework.
    Read more

  5. Webinar: How to use the Investigator's Brochure in de-risking a First-in-Human study

    During this webinar, we will focus on how to use the Investigator's Brochure to de-risk a First-in-Human (FIH) trial.  Speakers: Prof. Dr. Jan de Hoon and Dr. Thomas Lodeweyckx (UZ Leuven)
    Read more

  6. Webinar: IB for an early phase/FIH trial: more than just a regulatory document

    This online workshop will discuss the IB (Investigator's Brochure) structure, content and quality as important topics for all parties involved in planning, set-up, conduct and interpretation of a clinical study. Some practical highlights will be shared on challenges on writing a “good” IB for a FIH/Early Phase trial on the one hand, and on how to use it for an optimal benefit-risk assessment on the other hand. 
    Read more

Past events